Role of Helicobacter pylori gastritis in gastric atrophy, intestinal metaplasia, and gastric neoplasia

Microscopy Research and Technique

Volumn 48, Issue 6, 2000, Pages 313-320

  Smith, Vincent C ^a   Genta, Robert M ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELLS; CELL TYPES; CHRONIC GASTRITIS; DUODENAL ULCERS; GASTRIC LYMPHOMA; GASTRIC ULCERS; HELICOBACTER PYLORI; MUCOSA-ASSOCIATED LYMPHOID TISSUE; RATE OF INFECTIONS; WORLD POPULATION;

ARTICLE; CANCER RISK; CHRONIC GASTRITIS; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE METAPLASIA; LYMPHOID HYPERPLASIA; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; OUTCOMES RESEARCH; PATHOGENESIS; PRIORITY JOURNAL; STOMACH TUMOR;

HELICOBACTER PYLORI;

EID: 0034654179     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(20000315)48:6<313::AID-JEMT1>3.0.CO;2-Y     Document Type: Article

References (62)

1. Anonymous. 1993. Epidemiology of, and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 34:1672-1676.
2. Antonioli DA, Goldman H. 1982. Changes in the location and type of gastric adenocarcinoma. Cancer 50:775-781.
3. Bergenzaun P, Kristinsson KG, Thjodleifsson B, Sigvaldadottir E, Molstad S, Held M and Wadstrom T 1996. Seroprevalence of Helicobacter pylori in south Sweden and Iceland. Scand J Gastroenterol 31:1157-1161.
4. Blaser MJ. 1996. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Aliment Pharmacol Ther 10(Suppl 1):73-77.
5. Blaser MJ. 1999. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523-1530.
6. Correa P. 1995. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 19(Suppl 1):S37-43
7. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, Brown C, Haenszel W. 1976. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 57:1027-1035.
8. Dixon MF. 1991. Helicobacter pylori and peptic ulceration: histopathological aspects. J Gastroenterol Hepatol 6:125-130.
9. Dixon MF, Genta RM, Yardley JH, Correa P. 1996. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis Houston 1994. Am J Surg Pathol 20:1161-1181.
10. Dolan K, Sutton R, Walker SJ, Morris AI, Campbell F, Williams EM. 1999. New classification of oesophageal and gastric carcinomas derived from changing patterns in epidemiology. Br J Cancer 80: 834-842.
11. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. 1989. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321:1562-1566.
12. Eckardt VF. 1993. Early detection of gastrointestinal malignancies: what is new?. Bildgebung 60(Suppl 1):13-15.
13. el-Zimaity HM, Graham DY, al-Assi MT, Malaty H, Karttunen TJ, Graham DP, Huberman RM, Genta RM. 1996. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 27:35-41.
14. Figura N. 1996. Helicobacter pylori exotoxins and gastroduodenal diseases associated with cytotoxic strain infection. Aliment Pharmacol Ther 10(Suppl 1):79-96.
15. Forman D. 1995. The prevalence of Helicobacter pylori infection in gastric cancer. Aliment.Pharmacol.Ther. 9 Suppl 2:71-76.
16. Frommer DJ, Carrick J, Lee A, Hazell SL. 1988. Acute presentation of Campylobacter pylori gastritis. Am J Gastroenterol 83:1168-1171.
17. Genta RM. 1992. Counting angels and bacteria. The quest for a unifying theory of ulcerogenesis. Am J Clin Pathol 98:549-551.
18. Genta RM. 1995. Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol 7(Suppl 1):S25-30.
19. Genta RM. 1996. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 20(Suppl 1):S23-S30.
20. Genta RM. 1997. The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis 8:2-11.
21. Genta RM, Hamner HW, Graham DY. 1993. Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, response to triple therapy. Hum Pathol 24:577-583.
22. Genta RM, Gürer IE, Graham DY. 1995. Geographical pathology of Helicobacter pylori infection: is there more than one gastritis? Ann Med 27:595-599.
23. Genta RM, Gürer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O, Kim JG, Burchette JLJ. 1996. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 111:1206-1211.
24. Goldstone AR, Quirke P, Dixon MF. 1996. Helicobacter pylori infection and gastric cancer. J Pathol 179:129-137.
25. Graham DY, Malaty HM, Evans DG, Evans DJ.J, Klein PD, Adam E. 1991. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race , socioeconomic status. Gastroenterology 100:1495-1501.
26. Holcombe C, Omotara BA, Eldridge J, Jones DM. 1992. H. pylori, the most common bacterial infection in Africa: a random serological study. Am J Gastroenterol 87:28-30.
27. Hui PK, Chan WY, Cheung PS, Chan JK, Ng CS. 1992. Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol 23:548-556.
28. Isaacson PG. 1994a. Gastric lymphoma and Helicobacter pylori. N Engl J Med 330:1310-1311.
29. Isaacson PG. 1994b. Gastrointestinal lymphoma. Hum Pathol 25: 1020-1029.
30. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. 1997. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112: 1442-1447.
31. Malaty HM, Engstrand L, Pedersen NL, Graham DY. 1994. Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med 120:982-986.
32. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, Fontham ET, Mera R, Miller MJ, Correa P. 1996. Inducible nitric oxide synthase, nitrotyrosine, apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 56: 3238-3243.
33. Marshall BJ. 1995. The 1995 Albert Lasker Medical Research Award. Helicobacter pylori. The etiologic agent for peptic ulcer. JAMA 274:1064-1066.
34. Marshall BJ, Armstrong JA, McGechie DB, Glancy RJ. 1985. Attempt to fullfil Koch's postulates for pyloric Campylobacter. Med J Aust 142:436-439.
35. Meining A, Baverdorffer E, Bastlein E, Raudis N, Thiede C, Cyrus B, Kramer W, Klann H, Labenz J, Stolte M. 1997. Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn's disease. Crohn's Disease Study Group Germany. Scand J Gastroenterol 32:813-818.
36. Mitchell HM, Li YY, Hu PJ, Liu Q, Chen M, Du GG, Wang ZJ, Lee A, Hazell SL. 1992. Epidemiology of Helicobacter pylori in southern China: identification of early childhood as the critical period for acquisition. J Infect Dis 166:149-153.
37. Möller H, Heseltine E, Väiniö H. 1995. Working group report on schistosomes, liver flukes and Helicobacter pylori. Int J Cancer 60:587-589.
38. Morris A, Nicholson G. 1987. Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 82:192-199.
39. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. 1996. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 38:498-501.
40. Offerhaus GJ, Price AB, Haot J, Ten Kate FJ, Sipponen P, Fiocca R, Stolte M, Dixon MF. 1999. Observer agreement on the grading of gastric atrophy. Histopathology 34:320-325.
41. Ota H, Katsuyama T, Nakajima S, el-Zimaity H, Kim JG, Graham DY, Genta RM. 1998. Intestinal metaplasia with adherent Helicobacter pylori: a hybrid epithelium with both gastric and intestinal features. Hum Pathol 29:846-850.
42. Owen DA. 1986. Normal histology of the stomach. Am J Surg Pathol 10:48-61.
43. Parkin DM, Laara E, Muir CS. 1988. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184-197.
44. Parkin DM, Pisani P, Ferlay J. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841.
45. Parsonnet J. 1998. Helicobacter pylori: the size of the problem. Gut 43(Suppl 1):S6-S9.
46. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. 1991. Helicobacter pylori infection and the risk of gastric carcinoma . N Engl J Med 325:1127-1131.
47. Parsonnet J, Harris RA, Hack HM, Owens DK. 1996. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials . Lancet 348:150-154.
48. Pisani P, Parkin DM, Munoz N, Ferlay J. 1997. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6:387-400.
49. Queiroz DM, Rocha GA, Mendes EN, Carvalho AS, Barbosa AJ, Oliveira CA, Lima GFJ. 1991. Differences in distribution and severity of Helicobacter pylori gastritis in children and adults with duodenal ulcer disease. J Pediatr Gastroenterol Nutr 12:178-181.
50. Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. 1995. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. AmJ Epidemiol 142:856-863.
51. Rugge M, Di Mario F, Cassaro M, Baffa R, Farinati F, Rubio JJ, Ninfo V. 1993. Pathology of the gastric antrum and body associated with Helicobacter pylori infection in non-ulcerous patients: is the bacterium a promoter of intestinal metaplasia? Histopathology 22:9-15.
52. Silverberg E, Boring CC, Squires TS. 1990. Cancer Statistics, CA Cancer J Clin 40:9-26.
53. Sipponen P. 1989. Atrophic gastritis as a premalignant condition. Ann Med 21:287-290.
54. Sipponen P, Kimura K. 1994. Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time. Eur J Gastroenterol Hepatol 6(Suppl 1):S79-S83.
55. Sipponen P, Hyvärinen H, Siurala M. 1996. H. pylori corpus gastritis: relation to acid output. J Physiol Pharmacol 47:151-159.
56. Smoot DT. 1997. How does Helicobacter pylori cause mucosal damage? Direct mechanisms. Gastroenterology 113 S31-S34
57. Smoot DT, Resau JH, Naab T, Desbordes BC, Gilliam T, Bull-Henry K, Curry SB, Nidiry J, Sewchand J, Mills-Robertson K. 1993. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infect Immun 61:350-355.
58. Talley NJ. 1996. Helicobacter pylori and non-ulcer dyspepsia. Scand J Gastroenterol Suppl 220:19-22.
59. Tsutsumi Y, Nagura H, Watanabe K. 1984. Immune aspects of intestinal metaplasia of the stomach: an immunohistochemical study. Virchows Arch A Pathol Anat Histopathol 403:345-359.
60. Veldhuyzen vZS. 1997. The role of Helicobacter pylori infection in non-ulcer dyspepsia. Aliment Pharmacol Ther11(Suppl 1):63-9, 63-69.
61. Wijnhoven BP, Siersema PD, Hop WC, van Dekken H, Tilanus HW. 1999. Adenocarcinomas of the distal oesophagus and gastric cardia are one clinical entity.Rotterdam Oesophageal Tumour Study Group. Br J Surg 86:529-535.
62. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, De Boni M, Isaacson PG. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 342:575-577.